Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
High Street Pharmacies Spot Cancers In New NHS Early Diagnosis Drive
Staff in high street pharmacies will be funded to spot signs of cancer as part […]
One Million Checks Delivered By NHS ‘One Stop Shops’
NHS ‘one stop shops’ have delivered over one million checks and tests since the rollout […]
Aromatase Inhibitors Cut Breast Cancer Recurrence in Younger Patients
Drugs called aromatase inhibitors reduce the risk of breast cancer returning by compared with oestrogen […]
New Breast and Lung Cancer Treatments Approved in Scotland
3 new cancer treatments have now been approved by the Scottish Medicines Consortium (SMC) for […]
Targeted Drug Recommended to Treat Some Advanced Lung Cancer Patients
The National Institute for Health and Care Excellence (NICE) has recommended the use of selpercatinib (Retevmo) for […]
Immunotherapy Approved for Some People with Oesophageal Cancer on NHS in England
The National Institute for Health and Care Excellence (NICE) has recommended the use of the […]
New Chemotherapy-free Treatment for Bowel Cancer Made Available in Scotland
The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug pembrolizumab (Keytruda) for some adults with bowel cancer that’s […]
New Drug Combo for Advanced Breast Cancer Approved for NHS in England
The National Institute of Health and Care Excellence (NICE) has approved the use of a […]
New Option to Treat Advanced Oesophageal Cancer Approved for NHS in Scotland
The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug nivolumab (Opdivo) for patients with a type […]
First Treatment Approved in England for Advanced Bile Duct Cancer
The drug pemigatinib (Pemazyre) will now be an option for people with a rare type of bile […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more